Thyroid Cancer: Playing ‘Molecular Chess’ Against a Grandmaster
New research improves physicians' “molecular chess” game against thyroid cancer to overcome resistance to treatments.
New research improves physicians' “molecular chess” game against thyroid cancer to overcome resistance to treatments.
Twenty-one years ago this week, police officers, firefighters, paramedics, and volunteers converged on the remains of the World Trade...
On May 4, the U.S. Food and Drug Administration (FDA) approved a combination of molecularly targeted therapeutics for the...
Aime Franco, PhD, quietly battled cancer throughout her undergraduate years at the University of Connecticut. But even as she...
Yet more good news emanated from the U. S. Food and Drug Administration (FDA) last week when it announced...